{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:35:47Z","timestamp":1769582147166,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1053\/j.seminhematol.2003.11.008","type":"journal-article","created":{"date-parts":[[2004,2,10]],"date-time":"2004-02-10T10:35:52Z","timestamp":1076409352000},"page":"35-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"S1","title":["Dosing with recombinant factor viia based on current evidence"],"prefix":"10.1053","volume":"41","author":[{"given":"Ulla","family":"Hedner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2003.11.008_BIB1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI102477","article-title":"Congenital SPCA deficiency. A hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions","volume":"30","author":"Alexander","year":"1951","journal-title":"J Clin Invest"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2003.11.008_BIB2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00001721-200004001-00002","article-title":"The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation","volume":"11","author":"Allen","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.V99.3.923","article-title":"Mechanism of factor VIIa-dependent coagulation in hemophilia blood","volume":"99","author":"Butenas","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2516.2001.00553.x","article-title":"Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures","volume":"7","author":"Cooper","year":"2001","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB5","series-title":"Assay analyses in haemophilia patients with inhibitors under factor VIIa therapy","author":"Friedrich","year":"2003"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJM196902062800603","article-title":"Evaluation of a new concentrate for the treatment of factor IX deficiency","volume":"280","author":"Gilchrist","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB7","series-title":"Inhibitors to Coagulation Factors","first-page":"163","article-title":"Clinical update on the use of recombinant factor VIIa","author":"Glazer","year":"1995"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB8","first-page":"1","article-title":"Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody","volume":"21","author":"Gringeri","year":"1991","journal-title":"Haemostasis"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1055\/s-0038-1665434","article-title":"The treatment of bleeding in acquired haemophilia with recombinant factor VIIa","volume":"78","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB10","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001721-199008000-00009","article-title":"Factor VIIa in the treatment of haemophilia","volume":"1","author":"Hedner","year":"1990","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB12","first-page":"335","article-title":"Clinical experience with human plasma-derived factor VIIa in patients with hemophilia A and high titer inhibitors","volume":"19","author":"Hedner","year":"1989","journal-title":"Haemostasis"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","article-title":"Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy","volume":"2","author":"Hedner","year":"1988","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0955-3886(98)00026-5","article-title":"Clinical use of recombinant FVIIa (rFVIIa)","volume":"19","author":"Hedner","year":"1998","journal-title":"Transfus Sci"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB15","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI110939","article-title":"Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors","volume":"71","author":"Hedner","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB16","first-page":"355","article-title":"Pharmacokinetics of rFVIIa in children","volume":"4","author":"Hedner","year":"1998","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB17","first-page":"145","article-title":"Comparison of the effect of plasma-derived and recombinant human FVIIa in vitro and in a rabbit model","volume":"1","author":"Hedner","year":"1990","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB18","first-page":"270","article-title":"Comparison of the effect of factor VII prepared from human plasma (PVIIa and recombinant VIIa (RVIIa) in-vitro and in rabbits","volume":"58","author":"Hedner","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0038-1647933","article-title":"Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in-vivo","volume":"35","author":"Hedner","year":"1976","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1055\/s-0038-1656993","article-title":"Studies on the thrombogenic activities in two prothrombin complex concentrates","volume":"42","author":"Hedner","year":"1979","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood.V83.1.38.38","article-title":"Human monocytes support factor X activation by factor VIIa, independent of tissue factor","volume":"83","author":"Hoffman","year":"1994","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2003.11.008_BIB22","first-page":"118","article-title":"Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa","volume":"26","author":"Ingerslev","year":"1996","journal-title":"Haemostasis"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1538-7836.2003.00059.x","article-title":"A new approach to treatment of bleeding episodes in young hemophilia patients","volume":"1","author":"Kenet","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1055\/s-0037-1615388","article-title":"Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven\u00ae) in haemophiliacs with inhibitors","volume":"80","author":"Key","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB25","first-page":"451a","article-title":"Increased initial thrombin generation may explain the efficacy of high-dose factor VIIa in thrombocytopenia","volume":"94","author":"Kjalke","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/clpt.1994.80","article-title":"Pharmacokinetics and pharmacodynamics of recombinant factor VIIa","volume":"55","author":"Lindley","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl 6","key":"10.1053\/j.seminhematol.2003.11.008_BIB27","first-page":"3","article-title":"Thrombogenicity associated with factor IX complex concentrates","volume":"28","author":"Lusher","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1365-2516.1998.00209.x","article-title":"A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group","volume":"4","author":"Lusher","year":"1998","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB29","first-page":"228a","article-title":"Dose response of rFVIIa concentrate on hemostasis in hemophilia","volume":"94","author":"Melton","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB31","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","article-title":"Platelets and thrombin generation","volume":"22","author":"Monroe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0954-6820.1971.tb07427.x","article-title":"Clinical experience with a Swedish factor IX concentrate","volume":"190","author":"Nilsson","year":"1971","journal-title":"Acta Med Scand"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2003.11.008_BIB33","article-title":"The coagulation of blood","volume":"194","author":"Owren","year":"1947","journal-title":"Acta Med Scand"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB34","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood.V75.5.1069.1069","article-title":"Factor VIIa-catalyzed activation of factor X independent of tissue factor","volume":"75","author":"Rao","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB35","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1182\/blood.V53.5.828.828","article-title":"Activated factor VII","volume":"53","author":"Seligsohn","year":"1979","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","article-title":"Prospective, randomised trial of two doses of rFVIIa (NovoSeven\u00ae) in haemophilia patients with inhibitors undergoing surgery","volume":"80","author":"Shapiro","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0049-3848(96)00028-X","article-title":"Variability in platelet procoagulant activity in healthy volunteers","volume":"81","author":"Sumner","year":"1996","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0049-3848(89)90268-5","article-title":"Mechanism by which recombinant factor VIIa shortens the aPTT","volume":"56","author":"Telgt","year":"1989","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB39","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.V95.4.1330.004k28_1330_1335","article-title":"Inhibition of thrombin generation by the zymogen factor VII","volume":"95","author":"van\u2019t Veer","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.11.008_BIB40","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1016\/S0021-9258(19)83823-1","article-title":"The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen","volume":"257","author":"Zur","year":"1982","journal-title":"J Biol Chem"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196303003020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196303003020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:13:27Z","timestamp":1758521607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196303003020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":40,"alternative-id":["S0037196303003020"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2003.11.008","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosing with recombinant factor viia based on current evidence","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2003.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}